Literature DB >> 25609207

Fluoroscopy integrated 3D mapping significantly reduces radiation exposure during ablation for a wide spectrum of cardiac arrhythmias.

Marian Christoph1, Carsten Wunderlich2, Stefanie Moebius2, Mathias Forkmann2, Judith Sitzy2, Jozef Salmas2, Julia Mayer2, Yan Huo2, Christopher Piorkowski3, Thomas Gaspar3.   

Abstract

AIMS: Despite the use of established 3D-mapping systems, invasive electrophysiological studies and catheter ablation require high radiation exposure of patients and medical staff. This study investigated whether electroanatomic catheter tracking in prerecorded X-ray images on top of an existing 3D-mapping system has any impact on radiation exposure. METHODS AND
RESULTS: Two hundred and ninety-five consecutive patients were either ablated with the guidance of the traditional CARTO-3 system (c3) or with help of the CARTO-UNIVU system (cU): [typical atrial flutter (AFL) n = 58, drug refractory atrial fibrillation (AF) n = 81, ectopic atrial tachycardia (EAT) n = 37, accessory pathways (APs) n = 22, symptomatic, idiopathic premature ventricular complexes (PVCs) n = 56, ventricular tachycardias (VTs) n = 41]. The CARTO-UNIVU allowed a reduction in radiation exposure: fluoroscopy time: AFL c3: 8.6 ± 0.8 min vs. cU: 2.9 ± 0.3 min, P < 0.001; AF c3: 16.0 ± 1.3 min vs. cU: 6.4 ± 0.9 min, P < 0.001; EAT c3: 23.4 ± 3.1 min vs. cU: 9.7 ± 1.7 min, P < 0.001; AP c3: 7.1 ± 1.2 min vs. cU: 6.0 ± 1.5 min, P = 0.59; PVCs c3: 17.6 ± 2.3 min vs. cU: 15.2 ± 2.8 min, P = 0.52; VT c3: 31.4 ± 3.4 min vs. cU: 17.5 ± 2.4 min, P = 0.003. Corresponding to the fluoroscopy time the fluoroscopy dose was also reduced significantly. These advantages were not at the cost of increased procedure times, periprocedural complications, or decreased acute ablation success rates.
CONCLUSION: In a wide spectrum of cardiac arrhythmias, and especially in AF and VT ablation, fluoroscopy integrated 3D mapping contributed to a dramatic reduction in radiation exposure without prolonging procedure times and compromising patient's safety. That effect, however, could not be maintained in patients with APs and PVCs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  3D mapping; Ablation; Cardiac arrhythmias;; Fluoroscopy; Radiation exposure

Mesh:

Year:  2015        PMID: 25609207     DOI: 10.1093/europace/euu334

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  18 in total

Review 1.  3D Mapping for PVI- Geometry, Image Integration and Incorporation of Contact Force Into Work Flow.

Authors:  Martin Borlich; Leon Iden; Krister Kuhnhardt; Ingo Paetsch; Gerhard Hindricks; Philipp Sommer
Journal:  J Atr Fibrillation       Date:  2018-04-30

Review 2.  Mapping of atrial fibrillation: strategies to understand an enigmatic arrhythmia.

Authors:  Isabel Deisenhofer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-09-13

3.  Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches.

Authors:  Tina Baykaner; Kenneth K Quadros; Amit Thosani; Babak Yasmeh; Raman Mitra; Emerson Liu; William Belden; Zhigang Liu; Alex Costea; Chad R Brodt; Paul C Zei
Journal:  Pacing Clin Electrophysiol       Date:  2019-12-23       Impact factor: 1.976

4.  Reduction of Fluoroscopy Time and Radiation Dosage During Catheter Ablation for Atrial Fibrillation.

Authors:  Kenichiro Yamagata; Bashar Aldhoon; Josef Kautzner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

5.  Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage.

Authors:  Thomas Kleemann; Johannes Brachmann; Thorsten Lewalter; Dietrich Andresen; Stephan Willems; Stefan G Spitzer; Ellen Hoffmann; Lars Eckardt; Matthias Hochadel; Jochen Senges; Karl-Heinz Kuck; Karlheinz Seidl; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2016-05-03       Impact factor: 5.460

6.  Usefulness of a crista catheter for 3-dimensional electroanatomical mapping of complex right atrial tachyarrhythmias.

Authors:  Jae-Sun Uhm; Nam Kyun Kim; Hancheol Lee; Tae-Hoon Kim; Boyoung Joung; Hui-Nam Pak; Moon-Hyoung Lee
Journal:  J Interv Card Electrophysiol       Date:  2015-08-11       Impact factor: 1.900

7.  Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease.

Authors:  Óscar Cano; Assumpció Saurí; Diego Plaza; Joaquín Osca; María-José Sancho-Tello; Joaquín Rueda; Ana Osa; Luis Martínez-Dolz
Journal:  J Interv Card Electrophysiol       Date:  2018-10-30       Impact factor: 1.900

8.  Effect of Non-fluoroscopic Catheter Tracking on Radiation Exposure during Pulmonary Vein Isolation: Comparison of Four ablation systems.

Authors:  Yoshihisa Naruse; Fehmi Keçe; Marta de Riva; Masaya Watanabe; Adrianus P Wijnmaalen; Reza Alizadeh Dehnavi; Martin J Schalij; Katja Zeppenfeld; Serge A Trines
Journal:  J Atr Fibrillation       Date:  2018-10-31

9.  Ablation index-guided cavotricuspid isthmus ablation with contiguous lesions using fluoroscopy integrated 3D mapping in atrial flutter.

Authors:  Susumu Sakama; Atsuhiko Yagishita; Tetsuri Sakai; Masahiro Morise; Kengo Ayabe; Mari Amino; Yuji Ikari; Koichiro Yoshioka
Journal:  J Interv Card Electrophysiol       Date:  2022-03-16       Impact factor: 1.759

10.  Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial.

Authors:  Michela Casella; Antonio Dello Russo; Gemma Pelargonio; Maurizio Del Greco; Gianluca Zingarini; Marcello Piacenti; Andrea Di Cori; Victor Casula; Massimiliano Marini; Francesca Pizzamiglio; Martina Zucchetti; Stefania Riva; Eleonora Russo; Maria Lucia Narducci; Ezio Soldati; Luca Panchetti; Umberto Startari; Gianluigi Bencardino; Francesco Perna; Pasquale Santangeli; Luigi Di Biase; Fabrizio Cichocki; Giovanni Fattore; Mariagrazia Bongiorni; Eugenio Picano; Andrea Natale; Claudio Tondo
Journal:  Europace       Date:  2015-11-10       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.